News

Blinatumomab is the first of a new class of agents called BiTE antibodies, designed to harness the body’s T cells to kill cancer cells. As per the deal,

Gammagard Liquid is indicated as replacement therapy for primary humoral immunodeficiency in adult and pediatric patients two years of age or older. The submission of sBLA is backed

The study will compare safety and efficacy of Hospira’s EPO and the reference product, Amgen’s Epogen in patients with renal (kidney) dysfunction who have anemia. Erythropoietin is a

As per the alliance, Genentech has an exclusive license to compounds and a non-exclusive license to diagnostics from Xenon for development and commercialization of products. Xenon on the

Epanova increased EPA and DHA more than 5-Fold Compared to Lovaza After two weeks of dosing in 52 subjects on a low fat diet. Additionally, Epanova increased steady

Vitaros (alprostadil), indicated to treat erectile dysfunction (ED) is applied directly as a cream that boosts blood flow. According to the collaboration deal, Abbott will commercialize and market

IDX184 is an unpartnered, novel, liver-targeted nucleotide prodrug of 2′-methyl guanosine, and is currently being developed under a partial clinical hold. The randomized, double-blind parallel group Phase IIb

Polyplasdone PVPP is a synthetic polymer used as a tablet disintegrant and drug dissolution aid in a many over-the-counter and prescription drug products. The company is likely to

Relovair is a once-daily inhaled corticosteroid (ICS)/long-acting beta-agonist (LABA) combination treatment, comprising fluticasone furoate and vilanterol (FF/VI), currently in development for the treatment of COPD and asthma. The